,,iii #aaith ,,congress #b;d ,session ,s4 ,,res4 #ghf ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,june #bc1 #bjbf,mr4 ,graham 7for himself1 ,mr4 ,kelly1 ,mr4 ,barrasso1 ,mr4 ,scott of ,south ,carolina1 ,mr4 ,van ,hollen1 ,mr4 ,markey1 ,ms4 ,warren1 ,mr4 ,coons1 ,mr4 ,gallego1 and ,mrs4 ,shaheen7 submitted the following resolution2 which was considered and agreed to ,,resolution ,designating ,july #ae1 #bjbf1 as ,glioblastoma ,awareness ,day4 ,whereas it is estimated that more than #ac1jjj individuals in the ,united ,states will be diagnosed with glioblastoma in #bjbf2 ,whereas glioblastoma is-- 7#a7 the most common malignant 7cancerous7 brain tumor1 accounting for approximately #ab of all primary malignant brain tumors2 and 7#b7 the most aggressive1 complex1 difficult to treat1 and deadly type of brain tumor2 ,whereas it is estimated that more than #aj1jjj individuals in the ,united ,states will succumb to glioblastoma each year2 ,whereas the #e-year survival rate for glioblastoma is only #g percent1 and the median survival rate following all diagnosed cases is only #h months2 ,whereas glioblastoma is described as a disease that affects the essence of self1 as the treatment and removal of glioblastoma presents significant challenges due to the uniquely complex and fragile nature of the brain1 the primary organ in the human body that controls not only cognitive ability1 but also the actions of every organ and limb2 ,whereas patients and caregivers play a critical role in furthering research for glioblastoma2 ,whereas1 relative to patients with other types of cancers1 brain cancer patients pay the second highest out-of-pocket costs for medical services in both the initial and end-of-life phases of care2 ,whereas1 although research advances may fuel the development of new treatments for glioblastoma1 challenging obstacles to accelerating progress toward new treatments for glioblastoma remain1 and there are no screening or early detection methods2 ,whereas1 in #bjba1 significant changes were made to the molecular characteristics of a glioblastoma diagnosis1 necessitating critical biomarker testing for patients suspected of having a possible glioblastoma2 ,whereas1 although glioblastoma was first described in medical and scientific literature in the #aibjs1 and despite its devastating prognosis1 only #e drugs and #a medical device have been approved by the ,food and ,drug ,administration to specifically treat glioblastoma since the #aibjs1 and the mortality rates associated with glioblastoma have changed little during the past #cj years2 ,whereas1 since the first ,glioblastoma ,awareness ,day1 the ,national ,cancer ,institute established the ,glioblastoma ,therapeutics ,network 7referred to in this preamble as ,,gtn7 in #bjbj as part of a national infrastructure to enhance and support the discovery and development of glioblastoma therapies available for multi-institutional ,,gtn teams to drive therapeutic agents through preclinical studies and early phase clinical trials1 which are necessary to rapidly evaluate potential treatments to advance toward cures and improved quality of life2 and ,whereas there is a need for greater public awareness of glioblastoma1 including awareness of both-- 7#a7 the urgent unmet medical needs of glioblastoma patients2 and 7#b7 the opportunities for research of1 and treatment advances for1 glioblastoma3 ,now1 therefore1 be it ,that the ,senate-- 7#a7 designates ,july #ae1 #bjbf1 as ,glioblastoma ,awareness ,day2 7#b7 encourages increased public awareness of glioblastoma2 7#c7 honors the individuals who have died from the devastating disease of glioblastoma or are currently living with the disease2 7#d7 supports efforts to develop better treatments for glioblastoma that will improve the long-term prognosis for1 and the quality of life of1 individuals diagnosed with the disease2 7#e7 recognizes the importance of molecular biomarker testing to the diagnosis and treatment of glioblastoma2 7#f7 expresses support for the individuals who are battling brain tumors1 as well as the families1 friends1 and caregivers of those individuals2 7#g7 urges a collaborative approach to brain tumor research among governmental1 private1 and nonprofit organizations1 which is a promising means of advancing the understanding and treatment of glioblastoma2 and 7#h7 encourages continued investments in glioblastoma research and treatments1 including through the ,glioblastoma ,therapeutics ,network and other existing brain tumor research resources4